Qualigen Therapeutics, Inc.
QLGN
Revenue
1.63M
▲19.86k▲1.24%
3 Months ChangeAssets
2.31M
▲1.78M▲332.81%
3 Months ChangeLiabilities
4.14M
▼-1.82M▼-30.55%
3 Months ChangeFree Cash Flow
-2.83M
▲1.10M▲27.96%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-11-01
Form 8-K
ID: 0001493152-24-043352
2024-10-29
Form 8-K
ID: 0001493152-24-042874
2024-10-22
Form 8-K
ID: 0001493152-24-042068
2024-10-09
Form 8-K
ID: 0001493152-24-040599
2024-09-26
Form 8-K
ID: 0001493152-24-038351
2024-09-20
Form 8-K
ID: 0001493152-24-037600
2024-09-09
Form 8-K
ID: 0001493152-24-035508
2024-09-05
Form 8-K
ID: 0001493152-24-035102
2024-08-14
Form 10-Q
ID: 0001493152-24-032161
2024-08-05
Form 8-K
ID: 0001493152-24-030244